Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 208

Similar articles for PubMed (Select 23801834)

1.

Human liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinoma.

Liu SY, Zhang RL, Kang H, Fan ZJ, Du Z.

World J Gastroenterol. 2013 Jun 14;19(22):3423-32. doi: 10.3748/wjg.v19.i22.3423.

2.

Detection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MS.

Bowers J, Hughes E, Skill N, Maluccio M, Raftery D.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Sep 1;966:154-62. doi: 10.1016/j.jchromb.2014.02.043. Epub 2014 Mar 2.

PMID:
24666728
3.

LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort.

Xiao JF, Varghese RS, Zhou B, Nezami Ranjbar MR, Zhao Y, Tsai TH, Di Poto C, Wang J, Goerlitz D, Luo Y, Cheema AK, Sarhan N, Soliman H, Tadesse MG, Ziada DH, Ressom HW.

J Proteome Res. 2012 Dec 7;11(12):5914-23. doi: 10.1021/pr300673x. Epub 2012 Nov 1.

4.

Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma.

Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, Qi X, Cao Y, Su M, Wang X, Xu LX, Yen Y, Liu P, Jia W.

Mol Cell Proteomics. 2011 Jul;10(7):M110.004945. doi: 10.1074/mcp.M110.004945. Epub 2011 Apr 25. Erratum in: Mol Cell Proteomics. 2011 Nov;10(11). doi:10.1074/mcp.A110.004945.

5.

Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry.

Wang B, Chen D, Chen Y, Hu Z, Cao M, Xie Q, Chen Y, Xu J, Zheng S, Li L.

J Proteome Res. 2012 Feb 3;11(2):1217-27. doi: 10.1021/pr2009252. Epub 2012 Jan 18.

PMID:
22200553
6.

Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.

Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L.

J Gastroenterol Hepatol. 2009 Jan;24(1):55-62. doi: 10.1111/j.1440-1746.2008.05580.x. Epub 2008 Sep 24.

PMID:
18823443
7.

Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometry.

Cao H, Huang H, Xu W, Chen D, Yu J, Li J, Li L.

Anal Chim Acta. 2011 Apr 8;691(1-2):68-75. doi: 10.1016/j.aca.2011.02.038. Epub 2011 Feb 23.

PMID:
21458633
8.

Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC-MS/MS.

Baniasadi H, Gowda GA, Gu H, Zeng A, Zhuang S, Skill N, Maluccio M, Raftery D.

Electrophoresis. 2013 Oct;34(19):2910-7. doi: 10.1002/elps.201300029. Epub 2013 Sep 1.

9.
10.

Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis.

Ressom HW, Xiao JF, Tuli L, Varghese RS, Zhou B, Tsai TH, Ranjbar MR, Zhao Y, Wang J, Di Poto C, Cheema AK, Tadesse MG, Goldman R, Shetty K.

Anal Chim Acta. 2012 Sep 19;743:90-100. doi: 10.1016/j.aca.2012.07.013. Epub 2012 Jul 20.

11.

The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.

Darpolor MM, Basu SS, Worth A, Nelson DS, Clarke-Katzenberg RH, Glickson JD, Kaplan DE, Blair IA.

NMR Biomed. 2014 Apr;27(4):381-9. doi: 10.1002/nbm.3072. Epub 2014 Feb 4.

12.

(1)H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis.

Wang J, Zhang S, Li Z, Yang J, Huang C, Liang R, Liu Z, Zhou R.

Tumour Biol. 2011 Feb;32(1):223-31. doi: 10.1007/s13277-010-0116-7. Epub 2010 Oct 4.

PMID:
20890798
13.

Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.

Huang Q, Tan Y, Yin P, Ye G, Gao P, Lu X, Wang H, Xu G.

Cancer Res. 2013 Aug 15;73(16):4992-5002. doi: 10.1158/0008-5472.CAN-13-0308. Epub 2013 Jul 1.

14.

Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis.

Tan Y, Yin P, Tang L, Xing W, Huang Q, Cao D, Zhao X, Wang W, Lu X, Xu Z, Wang H, Xu G.

Mol Cell Proteomics. 2012 Feb;11(2):M111.010694. doi: 10.1074/mcp.M111.010694. Epub 2011 Nov 14.

15.

Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.

Zhang HJ, Yao DF, Yao M, Huang H, Wu W, Yan MJ, Yan XD, Chen J.

World J Gastroenterol. 2012 Nov 7;18(41):5897-904. doi: 10.3748/wjg.v18.i41.5897.

16.

Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice.

Li S, Liu H, Jin Y, Lin S, Cai Z, Jiang Y.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 15;879(24):2369-75. doi: 10.1016/j.jchromb.2011.06.018. Epub 2011 Jun 17.

PMID:
21763219
17.
18.

Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.

Wu H, Xue R, Dong L, Liu T, Deng C, Zeng H, Shen X.

Anal Chim Acta. 2009 Aug 19;648(1):98-104. doi: 10.1016/j.aca.2009.06.033. Epub 2009 Jun 21.

PMID:
19616694
19.

Expression of Ku86 and presence of Ku86 antibody as biomarkers of hepatitis B virus related hepatocellular carcinoma.

Xu Y, Liu AJ, Gao YX, Hu MG, Zhao GD, Zhao ZM, Liu R.

Dig Dis Sci. 2014 Mar;59(3):614-22. doi: 10.1007/s10620-013-2941-1. Epub 2013 Nov 24.

PMID:
24271118
20.

Serum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometry.

Zhou L, Ding L, Yin P, Lu X, Wang X, Niu J, Gao P, Xu G.

J Proteome Res. 2012 Nov 2;11(11):5433-42. doi: 10.1021/pr300683a. Epub 2012 Sep 28.

PMID:
22946841
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk